A high dose of an inexpensive and globally available blood-thinning medication reduces the risk of death in hospitalized patients who are moderately ill with COVID-19, suggests a new study led by St. Michael’s Hospital. Published today in the BMJ, the international RAPID Trial compared the effects of a high, therapeutic dose of heparin to a […]